DE19943743C2 - Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays - Google Patents

Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays

Info

Publication number: DE19943743C2
Authority: DE; Germany
Prior art keywords: array; ligate; bound; carrier material; cell lysate
Prior art date: 1999-09-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE19943743A

Other languages

German (de)

English (en)

Other versions

DE19943743A1 (de

Inventor

Eberhard Krause

Jens Schneider-Mergener

Thomas Bittorf

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Jerini AG

Original Assignee

JERINI BIOTOOLS GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-03

Filing date

1999-09-03

Publication date

2002-02-07

1999-09-03 Priority to DE19943743A priority Critical patent/DE19943743C2/de

1999-09-03 Application filed by JERINI BIOTOOLS GmbH filed Critical JERINI BIOTOOLS GmbH

2000-09-01 Priority to DE10082703T priority patent/DE10082703D2/de

2000-09-01 Priority to CZ2002660A priority patent/CZ2002660A3/cs

2000-09-01 Priority to JP2001522083A priority patent/JP2003511652A/ja

2000-09-01 Priority to EP00965834A priority patent/EP1212622A2/de

2000-09-01 Priority to PCT/DE2000/003071 priority patent/WO2001018545A2/de

2000-09-01 Priority to CA002386607A priority patent/CA2386607A1/en

2000-09-01 Priority to PL00353995A priority patent/PL353995A1/xx

2000-09-01 Priority to AU76442/00A priority patent/AU7644200A/en

2000-09-01 Priority to HU0203074A priority patent/HUP0203074A2/hu

2001-03-15 Publication of DE19943743A1 publication Critical patent/DE19943743A1/de

2002-02-07 Application granted granted Critical

2002-02-07 Publication of DE19943743C2 publication Critical patent/DE19943743C2/de

2019-09-04 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 63
238000003491 array Methods 0.000 title claims abstract description 8
239000003446 ligand Substances 0.000 claims abstract description 18
239000012876 carrier material Substances 0.000 claims abstract description 16
238000004949 mass spectrometry Methods 0.000 claims abstract description 13
239000000203 mixture Substances 0.000 claims abstract description 12
238000006243 chemical reaction Methods 0.000 claims abstract description 8
108090000765 processed proteins & peptides Proteins 0.000 claims description 65
108090000623 proteins and genes Proteins 0.000 claims description 62
102000004169 proteins and genes Human genes 0.000 claims description 57
102000004196 processed proteins & peptides Human genes 0.000 claims description 36
239000013592 cell lysate Substances 0.000 claims description 20
210000004027 cell Anatomy 0.000 claims description 16
150000001413 amino acids Chemical class 0.000 claims description 11
239000001913 cellulose Substances 0.000 claims description 11
229920002678 cellulose Polymers 0.000 claims description 11
239000012528 membrane Substances 0.000 claims description 10
239000006166 lysate Substances 0.000 claims description 9
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 7
108091005804 Peptidases Proteins 0.000 claims description 7
239000004365 Protease Substances 0.000 claims description 7
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 7
229960004452 methionine Drugs 0.000 claims description 7
150000001875 compounds Chemical class 0.000 claims description 6
238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 claims description 6
-1 polypropylene Polymers 0.000 claims description 6
238000012512 characterization method Methods 0.000 claims description 5
239000012634 fragment Substances 0.000 claims description 4
239000000463 material Substances 0.000 claims description 4
108020004707 nucleic acids Proteins 0.000 claims description 3
102000039446 nucleic acids Human genes 0.000 claims description 3
150000007523 nucleic acids Chemical class 0.000 claims description 3
238000005406 washing Methods 0.000 claims description 3
239000012130 whole-cell lysate Substances 0.000 claims description 3
239000004743 Polypropylene Substances 0.000 claims description 2
238000005119 centrifugation Methods 0.000 claims description 2
238000009833 condensation Methods 0.000 claims description 2
230000005494 condensation Effects 0.000 claims description 2
238000002330 electrospray ionisation mass spectrometry Methods 0.000 claims description 2
210000003527 eukaryotic cell Anatomy 0.000 claims description 2
238000001914 filtration Methods 0.000 claims description 2
229910021645 metal ion Inorganic materials 0.000 claims description 2
229920005597 polymer membrane Polymers 0.000 claims description 2
229920001155 polypropylene Polymers 0.000 claims description 2
238000001556 precipitation Methods 0.000 claims description 2
238000003498 protein array Methods 0.000 claims description 2
239000012508 resin bead Substances 0.000 claims description 2
238000004611 spectroscopical analysis Methods 0.000 claims description 2
235000004431 Linum usitatissimum Nutrition 0.000 claims 1
240000006240 Linum usitatissimum Species 0.000 claims 1
239000004677 Nylon Substances 0.000 claims 1
239000002253 acid Substances 0.000 claims 1
150000007513 acids Chemical class 0.000 claims 1
235000004426 flaxseed Nutrition 0.000 claims 1
238000001502 gel electrophoresis Methods 0.000 claims 1
229920001778 nylon Polymers 0.000 claims 1
235000018102 proteins Nutrition 0.000 description 50
102100036509 Erythropoietin receptor Human genes 0.000 description 18
108010075944 Erythropoietin Receptors Proteins 0.000 description 17
238000004458 analytical method Methods 0.000 description 13
230000003993 interaction Effects 0.000 description 13
230000001413 cellular effect Effects 0.000 description 11
102000003951 Erythropoietin Human genes 0.000 description 10
108090000394 Erythropoietin Proteins 0.000 description 10
229940105423 erythropoietin Drugs 0.000 description 10
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 9
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 9
108020003175 receptors Proteins 0.000 description 9
102000005962 receptors Human genes 0.000 description 9
101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 8
235000001014 amino acid Nutrition 0.000 description 7
230000003834 intracellular effect Effects 0.000 description 7
101000617285 Homo sapiens Tyrosine-protein phosphatase non-receptor type 6 Proteins 0.000 description 6
108010026552 Proteome Proteins 0.000 description 6
102100021657 Tyrosine-protein phosphatase non-receptor type 6 Human genes 0.000 description 6
230000029087 digestion Effects 0.000 description 6
230000006870 function Effects 0.000 description 6
238000000338 in vitro Methods 0.000 description 6
230000002285 radioactive effect Effects 0.000 description 6
239000003814 drug Substances 0.000 description 5
101000801228 Homo sapiens Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 4
102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 4
238000013459 approach Methods 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
229940125723 sedative agent Drugs 0.000 description 4
239000000932 sedative agent Substances 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
238000013519 translation Methods 0.000 description 4
238000010396 two-hybrid screening Methods 0.000 description 4
ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 3
229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 3
240000004808 Saccharomyces cerevisiae Species 0.000 description 3
235000012538 ammonium bicarbonate Nutrition 0.000 description 3
239000001099 ammonium carbonate Substances 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
238000011534 incubation Methods 0.000 description 3
239000008141 laxative Substances 0.000 description 3
229940125722 laxative agent Drugs 0.000 description 3
230000026731 phosphorylation Effects 0.000 description 3
238000006366 phosphorylation reaction Methods 0.000 description 3
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 3
230000008569 process Effects 0.000 description 3
NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
241001524679 Escherichia virus M13 Species 0.000 description 2
108091093037 Peptide nucleic acid Proteins 0.000 description 2
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
102000004142 Trypsin Human genes 0.000 description 2
108090000631 Trypsin Proteins 0.000 description 2
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 2
230000001548 androgenic effect Effects 0.000 description 2
229940125681 anticonvulsant agent Drugs 0.000 description 2
239000001961 anticonvulsive agent Substances 0.000 description 2
238000000376 autoradiography Methods 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
229940079593 drug Drugs 0.000 description 2
238000007876 drug discovery Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 2
238000012482 interaction analysis Methods 0.000 description 2
238000011835 investigation Methods 0.000 description 2
238000001819 mass spectrum Methods 0.000 description 2
238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
238000005259 measurement Methods 0.000 description 2
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
230000011664 signaling Effects 0.000 description 2
241000894007 species Species 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 2
239000012588 trypsin Substances 0.000 description 2
102000003298 tumor necrosis factor receptor Human genes 0.000 description 2
238000001419 two-dimensional polyacrylamide gel electrophoresis Methods 0.000 description 2
235000002374 tyrosine Nutrition 0.000 description 2
GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
208000010444 Acidosis Diseases 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
101000904177 Clupea pallasii Gonadoliberin-1 Proteins 0.000 description 1
101710094648 Coat protein Proteins 0.000 description 1
235000016795 Cola Nutrition 0.000 description 1
244000228088 Cola acuminata Species 0.000 description 1
235000011824 Cola pachycarpa Nutrition 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
101710102442 Erythropoietin receptor Proteins 0.000 description 1
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
102400000932 Gonadoliberin-1 Human genes 0.000 description 1
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
101500026183 Homo sapiens Gonadoliberin-1 Proteins 0.000 description 1
101000934996 Homo sapiens Tyrosine-protein kinase JAK3 Proteins 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
101150009057 JAK2 gene Proteins 0.000 description 1
229940124091 Keratolytic Drugs 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
101710125418 Major capsid protein Proteins 0.000 description 1
101710141454 Nucleoprotein Proteins 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
108010043958 Peptoids Proteins 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
101710083689 Probable capsid protein Proteins 0.000 description 1
102100027633 Protein FAN Human genes 0.000 description 1
101710198122 Protein FAN Proteins 0.000 description 1
102000001253 Protein Kinase Human genes 0.000 description 1
102000014400 SH2 domains Human genes 0.000 description 1
108050003452 SH2 domains Proteins 0.000 description 1
102100024550 Sphingomyelin phosphodiesterase 2 Human genes 0.000 description 1
101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
102100040247 Tumor necrosis factor Human genes 0.000 description 1
102100025387 Tyrosine-protein kinase JAK3 Human genes 0.000 description 1
101710112792 Tyrosine-protein kinase JAK3 Proteins 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
230000007950 acidosis Effects 0.000 description 1
208000026545 acidosis disease Diseases 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000000556 agonist Substances 0.000 description 1
229930013930 alkaloid Natural products 0.000 description 1
239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
229940124323 amoebicide Drugs 0.000 description 1
230000003321 amplification Effects 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
239000003098 androgen Substances 0.000 description 1
229940030486 androgens Drugs 0.000 description 1
229940035674 anesthetics Drugs 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000003266 anti-allergic effect Effects 0.000 description 1
230000002280 anti-androgenic effect Effects 0.000 description 1
230000003474 anti-emetic effect Effects 0.000 description 1
230000001567 anti-fibrinolytic effect Effects 0.000 description 1
239000000043 antiallergic agent Substances 0.000 description 1
239000000051 antiandrogen Substances 0.000 description 1
229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
239000000935 antidepressant agent Substances 0.000 description 1
229940005513 antidepressants Drugs 0.000 description 1
239000000729 antidote Substances 0.000 description 1
229940125683 antiemetic agent Drugs 0.000 description 1
239000002111 antiemetic agent Substances 0.000 description 1
239000000504 antifibrinolytic agent Substances 0.000 description 1
229940082620 antifibrinolytics Drugs 0.000 description 1
229940125715 antihistaminic agent Drugs 0.000 description 1
239000000739 antihistaminic agent Substances 0.000 description 1
239000002220 antihypertensive agent Substances 0.000 description 1
229940030600 antihypertensive agent Drugs 0.000 description 1
239000003430 antimalarial agent Substances 0.000 description 1
229940033495 antimalarials Drugs 0.000 description 1
230000008901 benefit Effects 0.000 description 1
229940049706 benzodiazepine Drugs 0.000 description 1
125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 1
239000002876 beta blocker Substances 0.000 description 1
229940097320 beta blocking agent Drugs 0.000 description 1
239000003781 beta lactamase inhibitor Substances 0.000 description 1
229940126813 beta-lactamase inhibitor Drugs 0.000 description 1
230000008827 biological function Effects 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
235000013877 carbamide Nutrition 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
230000008614 cellular interaction Effects 0.000 description 1
239000000812 cholinergic antagonist Substances 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
230000001427 coherent effect Effects 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
108010057085 cytokine receptors Proteins 0.000 description 1
102000003675 cytokine receptors Human genes 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
230000030609 dephosphorylation Effects 0.000 description 1
238000006209 dephosphorylation reaction Methods 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
239000002934 diuretic Substances 0.000 description 1
229940030606 diuretics Drugs 0.000 description 1
238000009509 drug development Methods 0.000 description 1
239000003596 drug target Substances 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
239000003172 expectorant agent Substances 0.000 description 1
230000003419 expectorant effect Effects 0.000 description 1
229940066493 expectorants Drugs 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
229930003935 flavonoid Natural products 0.000 description 1
150000002215 flavonoids Chemical class 0.000 description 1
235000017173 flavonoids Nutrition 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
239000000417 fungicide Substances 0.000 description 1
230000004927 fusion Effects 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
239000003193 general anesthetic agent Substances 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
229960001442 gonadorelin Drugs 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
150000001469 hydantoins Chemical class 0.000 description 1
239000003326 hypnotic agent Substances 0.000 description 1
230000000147 hypnotic effect Effects 0.000 description 1
229960001438 immunostimulant agent Drugs 0.000 description 1
239000003022 immunostimulating agent Substances 0.000 description 1
230000003308 immunostimulating effect Effects 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
150000002537 isoquinolines Chemical class 0.000 description 1
230000001530 keratinolytic effect Effects 0.000 description 1
239000003410 keratolytic agent Substances 0.000 description 1
238000002372 labelling Methods 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
230000004130 lipolysis Effects 0.000 description 1
230000003212 lipotrophic effect Effects 0.000 description 1
239000003912 lipotropic agent Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000003589 local anesthetic agent Substances 0.000 description 1
229960005015 local anesthetics Drugs 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
230000003547 miosis Effects 0.000 description 1
239000003604 miotic agent Substances 0.000 description 1
229940035363 muscle relaxants Drugs 0.000 description 1
230000035772 mutation Effects 0.000 description 1
239000002637 mydriatic agent Substances 0.000 description 1
230000002911 mydriatic effect Effects 0.000 description 1
239000003158 myorelaxant agent Substances 0.000 description 1
239000005445 natural material Substances 0.000 description 1
230000002276 neurotropic effect Effects 0.000 description 1
108040005466 neutral sphingomyelin phosphodiesterase activity proteins Proteins 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
230000037361 pathway Effects 0.000 description 1
238000002823 phage display Methods 0.000 description 1
239000003016 pheromone Substances 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000010399 physical interaction Effects 0.000 description 1
IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical class O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 description 1
239000002574 poison Substances 0.000 description 1
231100000614 poison Toxicity 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
239000000583 progesterone congener Substances 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
210000002307 prostate Anatomy 0.000 description 1
108060006633 protein kinase Proteins 0.000 description 1
230000004850 protein–protein interaction Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000014493 regulation of gene expression Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
210000001995 reticulocyte Anatomy 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
230000007781 signaling event Effects 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
229940124530 sulfonamide Drugs 0.000 description 1
150000003456 sulfonamides Chemical class 0.000 description 1
229940037128 systemic glucocorticoids Drugs 0.000 description 1
150000003505 terpenes Chemical class 0.000 description 1
235000007586 terpenes Nutrition 0.000 description 1
238000012360 testing method Methods 0.000 description 1
WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
150000003585 thioureas Chemical class 0.000 description 1
239000003204 tranquilizing agent Substances 0.000 description 1
230000002936 tranquilizing effect Effects 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
150000003918 triazines Chemical class 0.000 description 1
239000002753 trypsin inhibitor Substances 0.000 description 1
201000008827 tuberculosis Diseases 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
150000003668 tyrosines Chemical class 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
150000003672 ureas Chemical class 0.000 description 1
239000005526 vasoconstrictor agent Substances 0.000 description 1
229940124549 vasodilator Drugs 0.000 description 1
239000003071 vasodilator agent Substances 0.000 description 1
239000002544 virustatic Substances 0.000 description 1
230000001790 virustatic effect Effects 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
AFVLVVWMAFSXCK-UHFFFAOYSA-N α-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(C#N)=CC1=CC=C(O)C=C1 AFVLVVWMAFSXCK-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/02—Details
- H01J49/04—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Bioinformatics & Computational Biology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Analytical Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Food Science & Technology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Spectroscopy & Molecular Physics (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Optics & Photonics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

DE19943743A 1999-09-03 1999-09-03 Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays Expired - Fee Related DE19943743C2 (de)

Priority Applications (10)

Application Number	Priority Date	Filing Date	Title
DE19943743A DE19943743C2 (de)	1999-09-03	1999-09-03	Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays
AU76442/00A AU7644200A (en)	1999-09-03	2000-09-01	Method for identifying binding partners with position-specific arrays
JP2001522083A JP2003511652A (ja)	1999-09-03	2000-09-01	位置特異性配列を有する結合パートナーの特定方法
EP00965834A EP1212622A2 (de)	1999-09-03	2000-09-01	Verfahren zur identifizierung von bindungspartnern mit positions-spezifischen arrays
PCT/DE2000/003071 WO2001018545A2 (de)	1999-09-03	2000-09-01	Verfahren zur identifizierung von bindungspartnern mit positions-spezifischen arrays
CA002386607A CA2386607A1 (en)	1999-09-03	2000-09-01	Method for identifying binding partners with position-specific arrays
DE10082703T DE10082703D2 (de)	1999-09-03	2000-09-01	Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays (kein Eintritt in die nationale Phase erfolgt)
CZ2002660A CZ2002660A3 (cs)	1999-09-03	2000-09-01	Způsob identifikace vazebných partnerů pozičně specifickým testem
HU0203074A HUP0203074A2 (hu)	1999-09-03	2000-09-01	Eljárás kötőpartnerek azonosítására helyspecifikus tömbökkel
PL00353995A PL353995A1 (en)	1999-09-03	2000-09-01	Method for identifying binding partners with position-specific arrays

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19943743A DE19943743C2 (de)	1999-09-03	1999-09-03	Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays

Publications (2)

Publication Number	Publication Date
DE19943743A1 DE19943743A1 (de)	2001-03-15
DE19943743C2 true DE19943743C2 (de)	2002-02-07

Family

ID=7921806

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE19943743A Expired - Fee Related DE19943743C2 (de)	1999-09-03	1999-09-03	Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays
DE10082703T Expired - Lifetime DE10082703D2 (de)	1999-09-03	2000-09-01	Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays (kein Eintritt in die nationale Phase erfolgt)

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE10082703T Expired - Lifetime DE10082703D2 (de)	1999-09-03	2000-09-01	Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays (kein Eintritt in die nationale Phase erfolgt)

Country Status (9)

Country	Link
EP (1)	EP1212622A2 (cs)
JP (1)	JP2003511652A (cs)
AU (1)	AU7644200A (cs)
CA (1)	CA2386607A1 (cs)
CZ (1)	CZ2002660A3 (cs)
DE (2)	DE19943743C2 (cs)
HU (1)	HUP0203074A2 (cs)
PL (1)	PL353995A1 (cs)
WO (1)	WO2001018545A2 (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10141464A1 (de) *	2001-08-23	2004-03-04	Genprofile Ag I.Ins.	Sequenzvarianten des für neuropsychiatrische Krankheiten verantwortlichen Gens 22444 und deren Verwendung

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1319954A1 (en) *	2001-12-12	2003-06-18	Centre National de Genotypage	Methods for protein analysis using protein capture arrays
US7504364B2 (en)	2002-03-01	2009-03-17	Receptors Llc	Methods of making arrays and artificial receptors
US20030228709A1 (en) *	2002-03-25	2003-12-11	Kozlowski Roland Zbignieiw	Arrays
CN1665790A (zh)	2002-05-03	2005-09-07	莫莱丘莱尔探针公司	用于检测和分离磷酸化分子的组合物及方法
US7445894B2 (en)	2002-05-03	2008-11-04	Molecular Probes, Inc.	Compositions and methods for detection and isolation of phosphorylated molecules
US7469076B2 (en)	2003-09-03	2008-12-23	Receptors Llc	Sensors employing combinatorial artificial receptors
EP1613737A4 (en)	2003-03-28	2008-12-03	Receptors Llc	ARTIFICIAL RECEPTORS COMPRISING REVERSIBLE IMMOBILIZED CONSTRUCTION BLOCKS AND METHODS
US20040248323A1 (en)	2003-06-09	2004-12-09	Protometrix, Inc.	Methods for conducting assays for enzyme activity on protein microarrays
US7884052B2 (en)	2004-09-03	2011-02-08	Receptors Llc	Combinatorial artificial receptors including tether building blocks on scaffolds
EP1789792A2 (en)	2004-09-11	2007-05-30	Receptors LLC	Combinatorial artificial receptors including peptide building blocks

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4027675A1 (de) *	1990-08-31	1992-03-12	Biotechnolog Forschung Gmbh	Verfahren zur schnellen synthese von grossen zahlen traegergebundener oder freier peptide
US5821047A (en) *	1990-12-03	1998-10-13	Genentech, Inc.	Monovalent phage display

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5834318A (en) *	1995-05-10	1998-11-10	Bayer Corporation	Screening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins
WO1997043301A2 (en) *	1996-05-10	1997-11-20	Novartis Ag	Identification of members of combinatorial libraries by mass spectrometry
US6207370B1 (en) *	1997-09-02	2001-03-27	Sequenom, Inc.	Diagnostics based on mass spectrometric detection of translated target polypeptides
GB9800378D0 (en) *	1998-01-08	1998-03-04	Univ Liverpool	Proteome analysis

1999
- 1999-09-03 DE DE19943743A patent/DE19943743C2/de not_active Expired - Fee Related
2000
- 2000-09-01 DE DE10082703T patent/DE10082703D2/de not_active Expired - Lifetime
- 2000-09-01 CA CA002386607A patent/CA2386607A1/en not_active Abandoned
- 2000-09-01 AU AU76442/00A patent/AU7644200A/en not_active Abandoned
- 2000-09-01 WO PCT/DE2000/003071 patent/WO2001018545A2/de not_active Ceased
- 2000-09-01 EP EP00965834A patent/EP1212622A2/de not_active Withdrawn
- 2000-09-01 CZ CZ2002660A patent/CZ2002660A3/cs unknown
- 2000-09-01 JP JP2001522083A patent/JP2003511652A/ja active Pending
- 2000-09-01 HU HU0203074A patent/HUP0203074A2/hu unknown
- 2000-09-01 PL PL00353995A patent/PL353995A1/xx not_active Application Discontinuation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4027675A1 (de) *	1990-08-31	1992-03-12	Biotechnolog Forschung Gmbh	Verfahren zur schnellen synthese von grossen zahlen traegergebundener oder freier peptide
US5821047A (en) *	1990-12-03	1998-10-13	Genentech, Inc.	Monovalent phage display

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Biospektrum 5/98, S. 39-44 *
Camp.Meth.Enzymol. 1994, Bd. 6, S. 388-395 *
Clin.Chem.Lab.Med., Bd. 36, November 1998, S. 233-236 *
Meth.Mol.Biol. 1998, Bd. 87, S. 25-39 *
Nature Biotechnology, Bd. 17, März 1999, S. 233-236 *
Tetrahedron Letters 40(1999), S. 4317-4318 *
Tetrahedron, Bd. 48, Nr. 42, 1992, S. 9217-9232 *
TIBTECH 1998, Bd. 16, S. 355-363 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10141464A1 (de) *	2001-08-23	2004-03-04	Genprofile Ag I.Ins.	Sequenzvarianten des für neuropsychiatrische Krankheiten verantwortlichen Gens 22444 und deren Verwendung

Also Published As

Publication number	Publication date
WO2001018545A2 (de)	2001-03-15
AU7644200A (en)	2001-04-10
DE19943743A1 (de)	2001-03-15
EP1212622A2 (de)	2002-06-12
WO2001018545A3 (de)	2001-09-13
DE10082703D2 (de)	2002-02-14
CZ2002660A3 (cs)	2002-10-16
JP2003511652A (ja)	2003-03-25
CA2386607A1 (en)	2001-03-15
PL353995A1 (en)	2003-12-15
HUP0203074A2 (hu)	2002-12-28

Legal Events

Date	Code	Title	Description
2001-03-15	OP8	Request for examination as to paragraph 44 patent law
2002-02-07	D2	Grant after examination
2002-04-18	8327	Change in the person/name/address of the patent owner	Owner name: JERINI AG, 12489 BERLIN, DE
2002-08-01	8364	No opposition during term of opposition
2006-07-13	8339	Ceased/non-payment of the annual fee

Publication	Publication Date	Title
DE69912444T3 (de)	2010-05-06	Schnelle quantitative analyse von proteinen oder proteinfunktionen in komplexen gemischen
DE19943743C2 (de)	2002-02-07	Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays
DE60320207T2 (de)	2009-05-14	N- oder C-terminale Peptid-Auswahlmethode für Proteomics
DE60215498T2 (de)	2007-04-26	Verfahren zur bestimmung von polypeptiden
DE112005001166T5 (de)	2007-04-26	Verfahren und Vorrichtung zum Identifizieren von Proteinen in Gemischen
DE60109490T2 (de)	2006-04-13	Umgekehrtes labelierungsverfahren zur schnellen identifikation von marker/ziel-proteinen
Perdivara et al.	2013	Molecular characterization of collagen hydroxylysine O-glycosylation by mass spectrometry: current status
DE19802576B4 (de)	2004-10-28	Verfahren zur gleichzeitigen Identifizierung von Proteinen und ihren Bindungspartnern
DE102010051810B4 (de)	2013-06-27	Bilderzeugende Massenspektrometrie mit Protein-Identifizierung
DE10158860A1 (de)	2003-06-18	Massenspektrometrische Proteingemischanalyse
Wisztorski et al.	2008	Molecular MALDI imaging: an emerging technology for neuroscience studies
DE602004009824T2 (de)	2008-03-06	Analyse von massenspektraldaten in den ruhigen gebieten
EP1520177B1 (de)	2014-05-07	Verfahren und reagenz zur spezifischen identifizierung und quantifizierung von einem oder mehreren proteinen in einer probe
DE602004013350T2 (de)	2009-05-20	Elastinpeptid-fingerabdrücke und analyseverfahren für mit copd in verbindung stehendes mmp12
Getie et al.	2005	Characterization of peptides resulting from digestion of human skin elastin with elastase
DE60206526T2 (de)	2006-07-13	Nicht auf affinität basierende, isotopenmarkierte peptide und verfahren zu deren anwendung
DE69927668T2 (de)	2006-06-29	Massenfingerabdrucken und seiner verwendung zur identifizierung von protein-affinitätsliganden
DE60317904T2 (de)	2008-11-06	Ein verfahren zum identifizierung von arzneimittelzielen
Hummon et al.	2003	Discovering new neuropeptides using single-cell mass spectrometry
DE19854196C2 (de)	2001-03-15	Verfahren zur Modifikation und Identifikation funktioneller Stellen in Proteinen
WO2003098182A2 (de)	2003-11-27	Verfahren zur quantifizierung von molekülen
DE60211714T2 (de)	2007-05-10	Isolierung membrangebundener ligandenspezifischer komplexe
DE60120220T2 (de)	2007-03-29	Screening-verfahren auf basis der siah-numb-wechselwirkung
DE102008043241B3 (de)	2010-04-15	Verfahren zur massenspektrometrischen relativen Quantifizierung von Peptiden markiert mit 36S mittels metabolischer Markierung
EP1504267B1 (de)	2007-12-12	Festphasenassisitierte spektroskopische und spektrometrische analyse komplexer biopolymergemische

DE19943743C2 - Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (10)

Applications Claiming Priority (1)

Publications (2)

Family

ID=7921806

Family Applications (2)

Family Applications After (1)

Country Status (9)

Cited By (1)

Families Citing this family (10)

Citations (2)

Family Cites Families (4)

Patent Citations (2)

Non-Patent Citations (8)

Cited By (1)

Also Published As

Similar Documents

Legal Events